Epithelial Na+ channel inhibitors for the treatment of cystic fibrosis
In this patent review, brought to MedChemNet users by our sister journal Pharmaceutical Patent Analyst, the authors summarize their patent applications in regards to cystic fibrosis treatment via the inhibition of epithelial Na+ channels.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.